EQS-News: Abivax highlights obefazimod ulcerative colitis program with new data to be presented at the UEG Week 2023
EQS-News: ABIVAX / Key word(s): Study results Abivax highlights obefazimod ulcerative colitis program with new data...
Stay updated with breaking news from Mc Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EQS-News: ABIVAX / Key word(s): Study results Abivax highlights obefazimod ulcerative colitis program with new data...
EQS-News: ABIVAX / Key word(s): MiscellaneousAbivax files registration statement for proposed initial public offering in the United States 29.09.2023 / 23:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Abivax files registration statement for proposed initial public offering in the U...
EQS-News: ABIVAX / Key word: Half Year Report Abivax announces the release of its 2023 half-year financial report 29.09.2023 / 18:00 CET/CEST The issuer is...
EQS-News: ABIVAX / Key word(s): Half Year ReportAbivax announces the release of its 2023 half-year financial report 29.09.2023 / 18:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Abivax announces the release of its 2023 half-year financial report PARIS, France, September 2...
Issuer: Mainz BioMed N.V. / Key word: Conference/Study results Mainz Biomed to Present Detailed Results of ColoFuture Study at International Conference on...